Cargando…

Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non–Muscle-Invasive Bladder Cancer

IMPORTANCE: The BCG vaccine—used worldwide to prevent tuberculosis—confers multiple nonspecific beneficial effects, and intravesical BCG vaccine is currently the recommended treatment for non–muscle-invasive bladder cancer (NMIBC). Moreover, BCG vaccine has been hypothesized to reduce the risk of Al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinberg, Marc S., Zafar, Affan, Magdamo, Colin, Chung, Sun Young, Chou, Wesley H., Nayan, Madhur, Deodhar, Mayuresh, Frendl, Daniel M., Feldman, Adam S., Faustman, Denise L., Arnold, Steven E., Vakulenko-Lagun, Bella, Das, Sudeshna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199345/ https://www.ncbi.nlm.nih.gov/pubmed/37204792 http://dx.doi.org/10.1001/jamanetworkopen.2023.14336

Ejemplares similares

Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia
por: Charpignon, Marie-Laure, et al.
Publicado: (2022)

THU266 Lowered HbA1c In Individuals With Long-term Type 1 Diabetes Undergoing BCG Bladder Cancer Therapy
por: Dias, Hans, et al.
Publicado: (2023)

Fine and Coarse Particulate Matter Exposures and Associations with Acute Cardiac Events among Participants in a Telemedicine Service: A Case-Crossover Study
por: Nirel, Ronit, et al.
Publicado: (2018)

What is the adult experience of Perthes’ disease?: initial findings from an international web-based survey
por: McGuire, Molly F., et al.
Publicado: (2022)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies
por: Dias, Hans F., et al.
Publicado: (2023)

Bladder Cancer Immunotherapy: BCG and Beyond
por: Askeland, Eric J., et al.
Publicado: (2012)

BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation
por: Keefe, Ryan C., et al.
Publicado: (2021)

BCG Induced Necrosis of the Entire Bladder Urothelium
por: Krönig, Malte, et al.
Publicado: (2015)

Recognition and Treatment of BCG Failure in Bladder Cancer
por: Lightfoot, Andrew J., et al.
Publicado: (2011)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

THU284 BCG Clinical Trial Programs In Advanced Type 1 Diabetes - 2023 Update
por: Kühtreiber, Willem M, et al.
Publicado: (2023)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
por: Bhat, Suresh, et al.
Publicado: (2015)

Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer
por: Lukacs, S., et al.
Publicado: (2013)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
por: Lim, Chun Jye, et al.
Publicado: (2021)

BCG Vaccinations Upregulate Myc, a Central Switch for Improved Glucose Metabolism in Diabetes
por: Kühtreiber, Willem M., et al.
Publicado: (2020)

MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG
por: Saban, Marcia R, et al.
Publicado: (2011)

Bladder Sparing Therapy for BCG Failures – I – Intravesical Immunotherapy
por: Messing, Edward M.
Publicado: (2017)

Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer
por: Seegobin, Karan, et al.
Publicado: (2017)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Robust machine learning segmentation for large-scale analysis of heterogeneous clinical brain MRI datasets
por: Billot, Benjamin, et al.
Publicado: (2023)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
por: Kühtreiber, Willem M., et al.
Publicado: (2018)

BCG vaccinations drive epigenetic changes to the human T cell receptor: Restored expression in type 1 diabetes
por: Takahashi, Hiroyuki, et al.
Publicado: (2022)

BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis
por: Schwarzer, Katja, et al.
Publicado: (2010)

Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation: A case report
por: Moussa, M., et al.
Publicado: (2018)

Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
por: Kamat, Ashish M., et al.
Publicado: (2017)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer
por: Correa, Andres F., et al.
Publicado: (2015)

Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer
por: Mackel, Charles E, et al.
Publicado: (2016)

Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer
por: Ayati, Mohsen, et al.
Publicado: (2017)

Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)

Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes
por: Faustman, Denise L., et al.
Publicado: (2022)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
por: Ali-El-Dein, Bedeir, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tjt98kighfbc6bi6dpt7plou45